Selected article for: "excessive inflammatory response and inflammatory response"
Author: Ahn, Jin Young; Sohn, Yujin; Lee, Su Hwan; Cho, Yunsuk; Hyun, Jong Hoon; Baek, Yae Jee; Jeong, Su Jin; Kim, Jung Ho; Ku, Nam Su; Yeom, Joon-Sup; Roh, Juhye; Ahn, Mi Young; Chin, Bum Sik; Kim, Young Sam; Lee, Hyukmin; Yong, Dongeun; Kim, Hyun Ok; Kim, Sinyoung; Choi, Jun Yong
Title: Use of Convalescent Plasma Therapy in Two COVID-19 Patients with Acute Respiratory Distress Syndrome in Korea
  • Document date: 2020_4_6
    • ID: 1uwir5b8_22
    Snippet: Despite the limitations, our cases suggest that convalescent plasma from patients who have recovered from COVID-19 infection might be an additional option to treat patients without causing any severe adverse effects. Also, when used with systemic corticosteroids, we might expect the possibility of reducing excessive inflammatory response by corticosteroids as well as promoting the reduction of viral loads by convalescent plasma simultaneously. Fu.....
    Document: Despite the limitations, our cases suggest that convalescent plasma from patients who have recovered from COVID-19 infection might be an additional option to treat patients without causing any severe adverse effects. Also, when used with systemic corticosteroids, we might expect the possibility of reducing excessive inflammatory response by corticosteroids as well as promoting the reduction of viral loads by convalescent plasma simultaneously. Further well-designed studies are needed to demonstrate the efficacy and safety of convalescent plasma transfusion in COVID-19 patients.

    Search related documents:
    Co phrase search for related documents
    • additional option and design study: 1
    • additional option and inflammatory response: 1, 2
    • additional option and safety efficacy: 1, 2
    • adverse effect and convalescent plasma: 1, 2, 3, 4, 5, 6
    • adverse effect and design study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
    • adverse effect and inflammatory response: 1, 2, 3, 4, 5
    • adverse effect and patient treat: 1, 2
    • adverse effect and plasma transfusion: 1, 2, 3, 4
    • adverse effect and safety efficacy: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • adverse effect and severe adverse effect: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • adverse effect and severe adverse effect cause: 1
    • convalescent patient plasma transfusion and patient plasma transfusion: 1, 2, 3, 4, 5, 6
    • convalescent patient plasma transfusion and plasma transfusion: 1, 2, 3, 4, 5, 6
    • convalescent plasma and design study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • convalescent plasma and infection recover: 1, 2
    • convalescent plasma and inflammatory response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • convalescent plasma and patient plasma transfusion: 1, 2, 3, 4, 5, 6, 7, 8
    • convalescent plasma and patient treat: 1, 2, 3, 4
    • convalescent plasma and plasma transfusion: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25